Reflecting on Unmet Needs in Multiple Myeloma After IMS 2022

Video

Closing out their discussion, the panel highlights unmet needs in multiple myeloma that clinicians and patients still face.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.